Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Expression of antibody–drug conjugate targets in soft tissue sarcomas
François Bertucci, Pascal Finetti, Lénaïg Mescam, Audrey Monneur, A Frejafon, Axel Le Cesne, Isabelle Treilleux, Antoîne Italiano, M. Brahmi, Jean Yves Blay, Émilie Mamessier (2025). Expression of antibody–drug conjugate targets in soft tissue sarcomas. , 10(10), DOI: https://doi.org/10.1016/j.esmoop.2025.105837.
Article22 days ago216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort
Olivier Trédan, E.B. Saada, Cécile Dalban, Sophie Cousin, A. Le Cesne, A. Italiano, François Bertucci, C.A. Gomez-Roca, Lauriane Eberst, I. L. Ray-Coquard, Loïc Verlingue, P. Cassier, Valéry Attignon, Sylvie Chabaud, Romaine Mayet, E. Cauquil, G. Garin, David Pérol, Jean Yves Blay (2025). 216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort. , 36, DOI: https://doi.org/10.1016/j.annonc.2025.08.648.
Article22 days agoOutcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database
Emmanuelle Bompas, L. Campion, Maud Toulmonde, Axel Le Cesne, M. Saint‐Jean, Célèste Lebbé, Thibaud Valentin, María Rios, Florence Duffaud, Nelly Firmin, Sébastien Carrère, Sophie Piperno‐Neumann, Christophe Perrin, M. Ropars, Sylvie Bonvalot, Sarah Watson, Dimitri Tzanis, Pascaline Boudou-Roquette, Camille Tlemsani, Sixtine De Percin, Isabelle Desmoulin, Sylvain Causeret, Agnès Ducoulombier, Esma Saâda-Bouzid, François Bertucci, Jean‐Emmanuel Kurtz, Justine Gantzer, M. Brahmi, Armelle Dufresne, F. Gouin, Pierre Méeus, Antoine Italiano, Audrey Michot, Mariella Spatalo-Ceruso, Benjamin Verret, Charles Honoré, Thomas Ryckewaert, Gauthier Decanter, Jean-Camille Mattei, D. Gangloff, Sébastien Salas, B. Narciso, Camille Moreau-Bachelard, Louis‐Romée Le Nail, Pascale Dubray‐Longeras, F. Fiorenza, Loic Chagneau, Cécile Guillemet, Nicolas Penel, Jean Yves Blay (2025). Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database. , 229, DOI: https://doi.org/10.1016/j.ejca.2025.115788.
Article22 days agoCorrigendum to “Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)”
Emmanuelle Bompas, A. Le Cesne, Emmanuelle Tresch‐Bruneel, Loïc Lebellec, Valérie Laurence, Olivier Collard, Esma Saâda-Bouzid, Nicolás Isambert, Jean Yves Blay, Éric Amela, Sébastien Salas, Christine Chevreau, François Bertucci, Antoine Italiano, Stéphanie Clisant, Nicolas Penel (2025). Corrigendum to “Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)”. , 36 (12), DOI: https://doi.org/10.1016/j.annonc.2025.07.011.
Corrigendum22 days agoCO9.2 - Bayesian model using bivariate efficacy-tolerability outcome in patients with angiosarcoma to determine the safe most successful dose of propranolol in combination with metronomic fixed-dose cyclophosphamide: PROPAN a Phase I-II sequential trial
Eva Foinet, Eva Jouve, Sussan J. Salas, Jean Yves Blay, Christine Chevreau, A. Le Cesne, Emmanuelle Bompas, François Bertucci, Jean‐Emmanuel Kurtz, Nicolás Isambert, L. Chaigneau, Jake Micallef, Sarah Zohar (2025). CO9.2 - Bayesian model using bivariate efficacy-tolerability outcome in patients with angiosarcoma to determine the safe most successful dose of propranolol in combination with metronomic fixed-dose cyclophosphamide: PROPAN a Phase I-II sequential trial. , 73, DOI: https://doi.org/10.1016/j.jeph.2025.203016.
Article22 days ago